The Chemours Company last reported quarterly results on Nov 2, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $1.5 billion (+3.0% year over year) and diluted EPS of $1.29. It usually reports 33–50 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 18, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 19, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 33–50 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 2, 2026
33 days after quarter end
From press release
|
Q3 FY2026
ended Sep 30, 2026
|
1,540
+3.0%
|
196
+326.1%
|
1.29
+316.1%
|
|
Aug 4, 2026
35 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
1,591
-1.5%
|
-274
+27.9%
|
-1.81
+28.5%
|
|
May 5, 2026
35 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
1,381
+1.0%
|
-29
-480.0%
|
-0.19
-533.3%
|
|
Feb 19, 2026
50 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
1,329
-2.2%
|
-47
-327.3%
|
-0.31
-287.5%
|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
1,495
-0.9%
|
46
+243.8%
|
0.31
+240.9%
|
|
Aug 5, 2025
36 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
1,615
+3.9%
|
-380
-733.3%
|
-2.53
-748.7%
|
|
May 6, 2025
36 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
1,368
+0.4%
|
-5
-109.3%
|
-0.03
-108.3%
|
|
Feb 18, 2025
49 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
1,359
-0.7%
|
-11
+38.9%
|
-0.08
+33.3%
|
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- CC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1627223
- Former names
- Chemours Company, LLC (until Apr 21, 2015)
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Innospec Inc. IOSP
- OLIN Corp OLN
- Huntsman CORP HUN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.